Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jupiter Neurosciences, Inc. (JUNS)
NASDAQ:JUNS
Holding JUNS?
Track your performance easily
JUNS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.86 - $19.51
Previous Close$8.75
Volume254.80K
Average Volume (3M)507.71K
Market Cap
$281.38M
Enterprise Value$291.87M
Total Cash (Recent Filing)$14.85K
Total Debt (Recent Filing)$2.23M
Price to Earnings (P/E)―
Beta11.21
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding33,103,860
10 Day Avg. Volume272,219
30 Day Avg. Volume507,712
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-153.70
Forecast
1Y Price Target
$30.00Price Target Upside246.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
JUNS FAQ
What was Jupiter Neurosciences, Inc.’s price range in the past 12 months?
Jupiter Neurosciences, Inc. lowest stock price was $3.86 and its highest was $19.51 in the past 12 months.
What is Jupiter Neurosciences, Inc.’s market cap?
Currently, no data Available
When is Jupiter Neurosciences, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Jupiter Neurosciences, Inc.’s earnings last quarter?
Currently, no data Available
Is Jupiter Neurosciences, Inc. overvalued?
According to Wall Street analysts Jupiter Neurosciences, Inc.’s price is currently Undervalued.
Does Jupiter Neurosciences, Inc. pay dividends?
Jupiter Neurosciences, Inc. does not currently pay dividends.
What is Jupiter Neurosciences, Inc.’s EPS estimate?
Jupiter Neurosciences, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jupiter Neurosciences, Inc. have?
Jupiter Neurosciences, Inc. has 33,103,860 shares outstanding.
What happened to Jupiter Neurosciences, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Jupiter Neurosciences, Inc.?
Currently, no hedge funds are holding shares in JUNS
---
Jupiter Neurosciences, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Jupiter Neurosciences, Inc.
Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL¿ , has many potential indications of use for rare diseases, which of we primarily are targeting Mucopolysaccharidoses Type 1, Friedreichs Ataxia, and MELAS as well as ALS which is in an early development stage. In the larger disease areas, we are primarily targeting Mild Cognitive Impairment/early Alzheimers disease with TBI/concussions and Covid-19 in early development stages. Based on available scientific literature, we believe that JOTROL¿ is the first and only resveratrol product in the world that delivers a therapeutically effective dose of resveratrol in the blood stream without causing gastrointestinal side effects.
---
JUNS Stock 12 Month Forecast
Average Price Target
$30.00
▲(246.82% Upside)
Technical Analysis
Best Analysts Covering JUNS
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-19.40%
initiated a buy rating 23 days ago
Copying William Gregozeski's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -19.40% per trade.
---